Downregulation of Keap1, consequent to gene mutations or loss of heterozygosity in the Keap1 locus, has been identified in lung cancer cell lines or cancer tissues and results in an upregulation of Nrf2 and in transactivation of its downstream genes [214]. Here, NFE2L2 is linked to lung carcinoma.